Non-24-hour Sleep-wake Rhythm Disorder

• EMA approval · 2025-12-04
  EMA Authorised: Hetlioz (tasimelteon) — Vanda Pharmaceuticals Netherlands B.V.

  Hetlioz (tasimelteon) has been authorised in the EU for a circadian rhythm sleep-wake disorder, notably non-24-hour sleep-wake rhythm disord…

• CLINICAL_TRIALS research · 2025-08-03
  Clinical Trial Update: Biomarkers for Circadian Timing in Healthy Adults

  A terminated clinical trial at Brigham and Women's Hospital explored biomarkers for circadian timing in healthy adults.

• FDA approval · 2022-12-12
  FDA Approved: TASIMELTEON — Original Application (Teva Pharmaceuticals, Inc.)

  FDA approved tasimelteon under an original application for Teva Pharmaceuticals for the treatment of non-24-hour sleep-wake rhythm disorder …